The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
Jing Fu(Columbia University Irving Medical Center), Suzanne Lentzsch(UPMC Hillman Cancer Center)
Cited by 19
Related Papers
Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease
|Journal of Clinical Investigation|2016|73
Targeting the Microtubular Network as a New Antimyeloma Strategy
|Molecular Cancer Therapeutics|2011|28